Insider Selling: CME Group Inc. (NASDAQ:CME) Insider Sells 4,500 Shares of Stock

CME Group Inc. (NASDAQ:CME) insider Sunil Cutinho sold 4,500 shares of the business’s stock in a transaction that occurred on Wednesday, October 30th. The shares were sold at an average price of $226.64, for a total value of $1,019,880.00. Following the transaction, the insider now directly owns 27,053 shares in the company, valued at $6,131,291.92. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

CME Group Stock Up 0.1 %

Shares of CME stock traded up $0.17 during mid-day trading on Wednesday, hitting $227.26. The company’s stock had a trading volume of 1,211,235 shares, compared to its average volume of 1,921,584. CME Group Inc. has a 52-week low of $190.70 and a 52-week high of $230.36. The business has a 50-day moving average price of $219.69 and a 200 day moving average price of $209.10. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.02 and a current ratio of 1.02. The stock has a market cap of $81.83 billion, a price-to-earnings ratio of 25.84, a PEG ratio of 7.76 and a beta of 0.55.

CME Group (NASDAQ:CME) last posted its quarterly earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share for the quarter, topping the consensus estimate of $2.65 by $0.03. The firm had revenue of $1.58 billion during the quarter, compared to analysts’ expectations of $1.59 billion. CME Group had a return on equity of 12.82% and a net margin of 56.98%. The company’s revenue was up 18.4% on a year-over-year basis. During the same quarter in the previous year, the business earned $2.25 earnings per share. Research analysts predict that CME Group Inc. will post 10.04 EPS for the current fiscal year.

CME Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, September 25th. Investors of record on Monday, September 9th were given a dividend of $1.15 per share. This represents a $4.60 dividend on an annualized basis and a yield of 2.02%. The ex-dividend date was Monday, September 9th. CME Group’s dividend payout ratio (DPR) is presently 52.33%.

Analyst Ratings Changes

Several research firms recently weighed in on CME. Morgan Stanley lifted their price target on CME Group from $210.00 to $233.00 and gave the company an “equal weight” rating in a research report on Thursday, October 17th. Keefe, Bruyette & Woods lifted their price target on CME Group from $212.00 to $213.00 and gave the company a “market perform” rating in a research report on Thursday, July 25th. Piper Sandler lifted their price target on CME Group from $240.00 to $250.00 and gave the company an “overweight” rating in a research report on Monday. Deutsche Bank Aktiengesellschaft lifted their price target on CME Group from $193.00 to $200.00 and gave the company a “hold” rating in a research report on Thursday, August 15th. Finally, Citigroup boosted their target price on CME Group from $250.00 to $255.00 and gave the stock a “buy” rating in a report on Thursday, October 24th. Four research analysts have rated the stock with a sell rating, seven have given a hold rating and four have issued a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $222.73.

Institutional Trading of CME Group

A number of hedge funds have recently bought and sold shares of the company. Capital International Investors increased its position in CME Group by 24.1% during the first quarter. Capital International Investors now owns 15,809,175 shares of the financial services provider’s stock valued at $3,403,557,000 after acquiring an additional 3,069,806 shares during the last quarter. Ameriprise Financial Inc. increased its position in CME Group by 11.3% in the second quarter. Ameriprise Financial Inc. now owns 5,283,196 shares of the financial services provider’s stock worth $1,038,676,000 after buying an additional 537,758 shares in the last quarter. GUARDCAP ASSET MANAGEMENT Ltd increased its position in CME Group by 1.1% in the first quarter. GUARDCAP ASSET MANAGEMENT Ltd now owns 4,009,068 shares of the financial services provider’s stock worth $863,112,000 after buying an additional 43,293 shares in the last quarter. Raymond James & Associates increased its position in CME Group by 3.2% in the second quarter. Raymond James & Associates now owns 3,029,145 shares of the financial services provider’s stock worth $595,530,000 after buying an additional 94,302 shares in the last quarter. Finally, Legal & General Group Plc increased its position in CME Group by 6.6% in the second quarter. Legal & General Group Plc now owns 2,835,075 shares of the financial services provider’s stock worth $557,371,000 after buying an additional 176,004 shares in the last quarter. Hedge funds and other institutional investors own 87.75% of the company’s stock.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.